The PI3K/AKT/mTOR pathway is associated with the proliferation, migration, and survival of SCLC.49 Therefore, patients can be stratified by potential therapeutic targets using a sequencing-based comprehensive analysis. This evidence concerns the gene AKT1 and small cell lung carcinoma.